Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,840 shares at $83.58 ($154K) on 2019-02-06, disclosed to the SEC on 2019-02-08.
Open-market sale of $154k NBIX by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.58 | 920 | $77K | 50.0% |
| 2 | $83.58 | 920 | $77K | 50.0% |
| Total | $83.58 avg | 1,840 | $154K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |